Neovascularization induced around an artificial device implanted in the abdomen by the use of gelatinized fibroblast growth factor 2

Cell Transplantation

Volumn 18, Issue 5-6, 2009, Pages 683-688

  Yuasa, Takeshi ^a   Rivas Carrillo, Jorge D ^a   Navarro Alvarez, Nalú ^a   Soto Gutierrez, Alejandro ^a   Kubota, Yasuhiro ^a   Tabata, Yasuhiko ^b   Okitsu, Teru ^c   Noguchi, Hirofumi ^d,e   Matsumoto, Shinichi ^d,e   Nakaji, Shuhei ^e   Tanaka, Noriaki ^a   Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d BAYLOR RESEARCH INSTITUTE   (United States)

^e OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Bioartificial pancreas; Fibroblast growth factor 2; Neovascularization

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ETHYLENE VINYL ALCOHOL COPOLYMER; FIBROBLAST GROWTH FACTOR 2; GELATIN; GLUCOSE; INSULIN; POLYURETHAN;

ANGIOGENESIS; ARTICLE; ARTIFICIAL MEMBRANE; ARTIFICIAL PANCREAS; BIOARTIFICIAL ORGAN; BIOCOMPATIBILITY; DEVICE; FIBROGENESIS; GEL; HISTOLOGY; INFLAMMATORY INFILTRATE; NONHUMAN; OMENTUM; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 70349229278     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970901805-625     Document Type: Article

References (24)

1. Balamurugan, A. N.; Gu, Y.; Tabata, Y.; Miyamoto, M.; Cui, W.; Hori, H.; Satake, A.; Nagata, N.; Wang, W.; Inoue, K. Bioartificial pancreas transplantation at prevascularized intermuscular space: Effect of angiogenesis induction on islet survival. Pancreas 26:279-285; 2003. (Pubitemid 36384161)
2. Gazda, L. S.; Vinerean, H. V.; Laramore, M. A.; Diehl, C. H.; Hall, R. D.; Rubin, A. L.; Smith, B. H. Encapsulation of porcine islets permits extended culture time and insulin independence in spontaneously diabetic BB rats. Cell Transplant. 16:609-620; 2007.
3. Gillard, P.; Ling, Z.; Mathieu, C.; Crenier, L.; Lannoo, M.; Maes, B.; Roep, B.; Gorus, F.; Pipeleers, D.; Keymeulen, B. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. Transplantation 85:256-263; 2008. (Pubitemid 351156856)
4. Hirshberg, B.; Rother, K. I.; Digon, 3rd, B. J.; Lee, J.; Gaglia, J. L.; Hines, K.; Read, E. J.; Chang, R.; Wood, B. J.; Harlan, D. M. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: The National Institutes of Health experience. Diabetes Care 26:3288-3295; 2003.
5. Kobayashi, N. Bioartificial pancreas for the treatment of diabetes. Cell Transplant. 17:11-17; 2008.
6. Kobayashi, T.; Aomatsu, Y.; Iwata, H.; Kin, T.; Kanehiro, H.; Hisanaga, M.; Ko, S.; Nagao, M.; Nakajima, Y. Indefinite islet protection from autoimmune destruction in non-obese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 75:619-625; 2003. (Pubitemid 36337358)
7. Lacy, P. E.; Hegre, O. D.; Gerasimidi-Vazeou, A.; Gentile, F. T.; Dionne, K. E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254:1782-1784; 1991.
8. Lee, J. I.; Nishimura, R.; Sakai, H.; Sasaki, N.; Kenmochi, T. A newly developed immunoisolated bioartificial pancreas with cell sheet engineering. Cell Transplant. 17:51-59; 2008. (Pubitemid 351551380)
9. Maffi, P.; Bertuzzi, F.; De Taddeo, F.; Magistretti, P.; Nano, R.; Fiorina, P.; Caumo, A.; Pozzi, P.; Socci, C.; Venturini, M.; del Maschio, A.; Secchi, A. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy. Diabetes Care 30:1150-1155; 2007. (Pubitemid 46684640)
10. Miki, A.; Rivas-Carrillo, J. D.; Navarro-Alvarez, N.; Soto- Gutierrez, A.; Chen, Y.; Tanaka, K.; Narushima, M.; Tabata, Y.; Okitsu, T.; Noguchi, H.; Matsumoto, S.; Tanaka, N.; Kobayashi, N. Maintenance of neovascularization at the implantation site of an artificial device by bFGF and endothelial cell transplant. Cell Transplant. 15: 893-901; 2006. (Pubitemid 46174539)
11. Navarro-Alvarez, N.; Rivas-Carrillo, J. D.; Soto-Gutierrez, A.; Yuasa, T.; Okitsu, T.; Noguchi, H.; Matsumoto, S.; Takei, J.; Tanaka, N.; Kobayashi, N. Reestablishment of microenvironment is necessary to maintain in vitro and in vivo human islet function. Cell Transplant. 17:111-119; 2008. (Pubitemid 351551386)
12. Noguchi, H.; Matsumoto, S. Islet transplantation at the Dicells abetes Research Institute Japan. J. Hepatobiliary. Pancreat. Surg. 15:278-283; 2008.
13. Noguchi, H.; Yamada, Y.; Okitsu, T.; Iwanaga, Y.; Nagata, H.; Kobayashi, N.; Hayashi, S.; Matsumoto, S. Secretory unit of islet in transplantation (SUIT) and engrafted islet rate (EIR) indexes are useful for evaluating single islet transplantation. Cell Transplant. 17:121-128; 2008. (Pubitemid 351551387)
14. Omer, A.; Duvivier-Kali, V. F.; Trivedi, N.; Wilmot, K.; Bonner-Weir, S.; Weir, G. C. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 52:69-75; 2003.
15. Ricordi, C.; Strom, T. B. Clinical islet transplantation: Advances and immunological challenges. Nat. Rev. Immunol. 4:259-268; 2004.
16. Ryan, E. A.; Lakey, J. R.; Paty, B. W.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Bigam, D.; Rajotte, R. V.; Shapiro, A. M. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157; 2002.
17. Sakata, N.; Gu, Y.; Qi, M.; Yamamoto, C.; Hiura, A.; Sumi, S.; Sunamura, M.; Matsuno, S.; Inoue, K. Effect of rat-to-mouse bioartificial pancreas xenotransplantation on diabetic renal damage and survival. Pancreas 32:249-257; 2006. (Pubitemid 43753965)
18. Sakata, N.; Sumi, S.; Gu, Y.; Qi, M.; Yamamoto, C.; Sunamura, M.; Egawa, S.; Unno, M.; Matsuno, S.; Inoue, K. Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation. Pancreas 34:458-465; 2007.
19. Sakurai, T.; Satake, A.; Nagata, N.; Gu, Y.; Hiura, A.; Doo-Hoon, K.; Hori, H.; Tabata, Y.; Sumi, S.; Inoue, K. The development of new immunoisolatory devices possessing the ability to induce neovascularization. Cell Transplant. 12:527-535; 2003. (Pubitemid 36993196)
20. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
21. Shapiro, A. M.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, R. P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejandro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisenbarth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L.; Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355:1318-1330; 2006.
22. Street, C. N.; Lakey, J. R.; Shapiro, A. M.; Imes, S.; Rajotte, R. V.; Ryan, E. A.; Lyon, J. G.; Kin, T.; Avila, J.; Tsujimura, T.; Korbutt, G. S. Islet graft assessment in the Edmonton Protocol: Implications for predicting long-term clinical outcome. Diabetes 53:3107-3114; 2004.
23. Toso, C.; Baertschiger, R.; Morel, P.; Bosco, D.; Armanet, M.; Wojtusciszyn, A.; Badet, L.; Philippe, J.; Becker, C. D.; Hadaya, K.; Majno, P.; Buhler, L.; Berney, T. Sequential kidney/islet transplantation: Efficacy and safety assessment of a steroid-free immunosuppression protocol. Am. J. Transplant. 6:1049-1058; 2006.
24. Weber, L. M.; Cheung, C. Y.; Anseth, K. S. Multifunctional pancreatic islet encapsulation barriers achieved via multilayer PEG hydrogels. Cell Transplant. 16:1049-1057; 2007.